Shiga, Japan

Reiji Ichinose

This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reiji Ichinose. Retrieved from https://idiyas.com/inventor/reiji-ichinose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Reiji Ichinose

Introduction: Reiji Ichinose is a notable inventor based in Shiga-ken, Japan, recognized for his contributions to the field of chemistry, particularly in the development of milbemycin derivatives. With one patent to his name, Ichinose has made significant strides in his area of expertise, showcasing the innovative spirit that drives the industry forward.

Latest Patents: One of Ichinose's most significant patents is titled "13-substituted milbemycin derivatives, their preparation and their use." This patent describes the formulation of 13-substituted milbemycin derivatives with specific chemical structures, contributing to advancements in pharmaceutical applications that target various biological systems.

Career Highlights: Reiji Ichinose is currently employed at Sankyo Company, Limited, where he actively participates in research and development. His work has not only contributed to the scientific community but also enhances the reputation of his company as a leader in pharmaceutical innovations.

Collaborations: Throughout his career, Ichinose has worked alongside talented colleagues such as Hideo Takeshiba and Kazuo Sato. These collaborations have likely fostered a rich exchange of ideas and have contributed to the innovative outcomes achieved in their joint projects.

Conclusion: Reiji Ichinose stands out as an accomplished inventor whose work on milbemycin derivatives illustrates the impact of dedicated research in the pharmaceutical sector. His patent and collaborative efforts at Sankyo Company, Limited reflect the innovative advancements that continue to emerge in the field, paving the way for future discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…